Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis. 1997

R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
Dept. 47 K, Abbott Laboratories, Abbott Park, Illinois 60064, USA.

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011804 Quinolines
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000001 Calcimycin An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports CALCIUM and other divalent cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))-,A-23187,A23187,Antibiotic A23187,A 23187,A23187, Antibiotic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015289 Leukotrienes A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system. Leukotriene
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
January 1984, Biochimica et biophysica acta,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
June 1983, Prostaglandins,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
February 2013, Chemical research in toxicology,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
January 1991, Skin pharmacology : the official journal of the Skin Pharmacology Society,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
January 1993, Journal of lipid mediators,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
January 1999, Advances in experimental medicine and biology,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
February 1995, Journal of applied physiology (Bethesda, Md. : 1985),
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
June 1983, Proceedings of the National Academy of Sciences of the United States of America,
R L Bell, and R R Harris, and J B Bouska, and K I Hulkower, and J Moore, and P Bhatia, and P E Malo, and T Kalosa, and C D Brooks, and G W Carter
October 1992, Journal of neurology,
Copied contents to your clipboard!